SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lupus study aims to match drugs to immune profiles
Disease control TerminatedThis study tested two lupus medications—mycophenolate mofetil alone or with voclosporin—in 12 adults with moderate-to-severe lupus. Researchers wanted to see if treatment response differs based on a person's immune system type. The goal was to find better ways to tailor therapy, …
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lupus flare prevention drug trial halted early
Disease control TerminatedThis study tested whether PRV-3279 could help prevent lupus flares in people with active systemic lupus erythematosus (SLE) whose disease had improved after steroid treatment. The trial was stopped early and included 28 participants. The main goal was to see if the drug could kee…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lupus drug trial halted early: what we know
Disease control TerminatedThis study tested a drug called telitacicept in people with moderate-to-severe lupus, an autoimmune disease. The goal was to see if it could reduce disease activity and allow lower steroid use. The trial was stopped early, but results may still help researchers understand lupus t…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated May 12, 2026 13:39 UTC